Network analysis of matched sets
For all three outcomes, direct and indirect comparisons between Group A
and Group B subjects were consistent, so it was justified to combine
then (Figure 4): there was no indication that outpatients prescribed
fluvoxmine around the time of COVID-19 diagnosis (Group A) were at a
reduced risk of any of the outcomes as compared to their peers burdened
with similar psychiatric difficulties but not prescribed fluvoxamine
over the critical period of time (Group B) (Figure 4). Closely similar
patterns were seen for the Group A vs. Group C comparisons (not shown).